Add to ORKGThis editorial refers to ‘Inhibition of delta-protein kinase C by delcasertib as an adjunct to primary percutaneous coron-ary intervention for acute anterior ST-segment elevation myocardial infarction: results of the PROTECTION AMI Randomized Controlled Trial’†, by A.M. Lincoff et al., o
In the current issue of the journal, Karlsson et al. present a feasibility study in patients with ST...
Primary percutaneous coronary intervention (PCI) represents the greatest progress in the treatment o...
This editorial refers to 'Long-term clinical outcomes after rescue angioplasty are not different fro...
AIMS: Delcasertib is a selective inhibitor of delta-protein kinase C (delta-PKC), which reduced infa...
Item does not contain fulltextAIMS: Delcasertib is a selective inhibitor of delta-protein kinase C (...
This editorial refers to ‘Exenatide reduces reperfusion injury in patients with ST-segment elevation...
This editorial refers to ‘Long-term clinical outcomes after rescue angioplasty are not different fro...
This editorial refers to ‘Cardioprotection by combined in-trahospital remote ischaemic perconditioni...
This editorial refers to ‘Impact of time to therapy and reperfusion modality on the efficacy of aden...
This editorial refers to ‘Effect of intravenous TRO40303 as an adjunct to primary percutaneous coron...
This editorial refers to ‘Meta-analysis of randomized trials on drug-eluting stents vs. bare-metal s...
This editorial refers to ‘Does time matter? A pooled analysis of randomized clinical trials comparin...
R eperfusion therapy of evolving myocardial infarction has significantly improved its short- and lon...
This editorial refers to ‘Plasma levels of thromboxane A2 on admission are associated with no-reflow...
reperfusion therapy in acute ST-elevation myocardial infarction by a pharmaco-invasive treatment app...
In the current issue of the journal, Karlsson et al. present a feasibility study in patients with ST...
Primary percutaneous coronary intervention (PCI) represents the greatest progress in the treatment o...
This editorial refers to 'Long-term clinical outcomes after rescue angioplasty are not different fro...
AIMS: Delcasertib is a selective inhibitor of delta-protein kinase C (delta-PKC), which reduced infa...
Item does not contain fulltextAIMS: Delcasertib is a selective inhibitor of delta-protein kinase C (...
This editorial refers to ‘Exenatide reduces reperfusion injury in patients with ST-segment elevation...
This editorial refers to ‘Long-term clinical outcomes after rescue angioplasty are not different fro...
This editorial refers to ‘Cardioprotection by combined in-trahospital remote ischaemic perconditioni...
This editorial refers to ‘Impact of time to therapy and reperfusion modality on the efficacy of aden...
This editorial refers to ‘Effect of intravenous TRO40303 as an adjunct to primary percutaneous coron...
This editorial refers to ‘Meta-analysis of randomized trials on drug-eluting stents vs. bare-metal s...
This editorial refers to ‘Does time matter? A pooled analysis of randomized clinical trials comparin...
R eperfusion therapy of evolving myocardial infarction has significantly improved its short- and lon...
This editorial refers to ‘Plasma levels of thromboxane A2 on admission are associated with no-reflow...
reperfusion therapy in acute ST-elevation myocardial infarction by a pharmaco-invasive treatment app...
In the current issue of the journal, Karlsson et al. present a feasibility study in patients with ST...
Primary percutaneous coronary intervention (PCI) represents the greatest progress in the treatment o...
This editorial refers to 'Long-term clinical outcomes after rescue angioplasty are not different fro...